Quercetin and Morin dual drug loaded nanostructured lipid carriers: formulation and in vitro cytotoxicity study on MCF7 breast cancer cells

References

• Zhang, Z.; Ni, C.; Chen, W.; Wu, P.; Wang, Z.; Yin, J.; Huang, J.; Qiu, F. Expression of CXCR4 and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis. BMC Cancer. 2014, 14, 49. DOI: 10.1186/1471-2407-14-49.
   PubMed Web of Science ®Google Scholar
• Poonia, N.; Narang, J. K.; Lather, V.; Beg, S.; Sharma, T.; Singh, B.; Pandita, D. Resveratrol Loaded Functionalized Nanostructured Lipid Carriers for Breast Cancer Targeting: Systematic Development, Characterization and Pharmacokinetic Evaluation. Colloids Surf. B Biointerf. 2019, 181, 756–766. DOI: 10.1016/j.colsurfb.2019.06.004.
   PubMed Web of Science ®Google Scholar
• Ma, Z.; Fan, Y.; Wu, Y.; Kebebe, D.; Zhang, B.; Lu, P.; Pi, J.; Liu, Z. Traditional Chinese Medicine-Combination Therapies Utilizing Nanotechnology-Based Targeted Delivery Systems: A New Strategy for Antitumor Treatment. Int. J. Nanomed. 2019, 14, 2029–2053. DOI: 10.2147/IJN.S197889.
   PubMed Web of Science ®Google Scholar
• Pund, S.; Thakur, R.; More, U.; Joshi, A. Lipid Based Nanoemulsifying Resveratrol for Improved Physicochemical Characteristics, In vitro Cytotoxicity and In vivo Antiangiogenic Efficacy. Colloids Surf. B Biointerf. 2014, 120, 110–117. DOI: 10.1016/j.colsurfb.2014.05.016.
   PubMed Web of Science ®Google Scholar
• Palei, N. N.; Krishnan, S. N.; Jayaraman, R.; Reddy, S. H.; Balaji, A.; Samanta, M. K.; Mohanta, B. C. Green Synthesis of Silver Nanoparticles of Vernonia Cinerea Leaf Extract and Their in Vitro Cytotoxicity Activity against Neuroblastoma SHSY-5Y Cell Lines, Antimicrobial, and Antioxidant Studies. NANOTEC. 2023, 17, 270–280. DOI: 10.2174/1872210516666220520144453.
   Web of Science ®Google Scholar
• Xu, G.; Shi, H.; Ren, L.; Gou, H.; Gong, D.; Gao, X.; Huang, N. Enhancing the anti-Colon Cancer Activity of Quercetin by Self-Assembled Micelles. Int. J. Nanomed. 2015, 10, 2051–2063. DOI: 10.2147/IJN.S75550.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Tang, Z. G.; Lin, Y.; Qu, X. G.; Lv, W.; Wang, G. B.; Li, C. L. Effects of Quercetin on Proliferation and Migration of Human Glioblastoma U251 Cells. Biomed. Pharmacother. 2017, 92, 33–38. DOI: 10.1016/j.biopha.2017.05.044.
   PubMed Web of Science ®Google Scholar
• Rauf, A.; Imran, M.; Khan, I. A.; Ur-Rehman, M.; Gilani, S. A.; Mehmood, Z.; Mubarak, M. S. Anticancer Potential of Quercetin: A Comprehensive Review. Phytother. Res. 2018, 32, 2109–2130. DOI: 10.1002/ptr.6155.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Zhang, H.; Cui, H.; Zhang, F.; Zhao, L.; Liu, Y.; Meng, Q. Combined and Targeted Drugs Delivery System for Colorectal Cancer Treatment: Conatumumab Decorated, Reactive Oxygen Species Sensitive Irinotecan Prodrug and Quercetin co-Loaded Nanostructured Lipid Carriers. Drug Deliv. 2022, 29, 342–350. DOI: 10.1080/10717544.2022.2027573.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y. I.; Ishihara, C.; Onishi, H. Formulation and Evaluation of Morin-Loaded Solid Lipid Nanoparticles. Biol. Pharm. Bull. 2016, 39, 1514–1522. DOI: 10.1248/bpb.b16-00300.
   PubMed Web of Science ®Google Scholar
• Choi, Y. A.; Yoon, Y. H.; Choi, K.; Kwon, M.; Goo, S. H.; Cha, J. S.; Choi, M. K.; Lee, H. S.; Song, I. S. Enhanced Oral Bioavailability of Morin Administered in Mixed Micelle Formulation with Pluronic F127 and Tween 80 in Rats. Biol. Pharm. Bull. 2015, 38, 208–217. DOI: 10.1248/bpb.b14-00508.
   PubMed Web of Science ®Google Scholar
• Rajput, S. A.; Wang, X.; Yan, H. C. Morin Hydrate: A Comprehensive Review on Novel Natural Dietary Bioactive Compound with Versatile Biological and Pharmacological Potential in Treating Cancers. Biomed. Pharmacother. 2021, 138, 111511. DOI: 10.1016/j.biopha.2021.111511
   PubMed Web of Science ®Google Scholar
• Li, S.; Zhang, B.; Jiang, D.; Wei, Y.; Zhan, G. N. Herb Network Construction and co-Module Analysis for Uncovering the Combination Rule of Traditional Chinese Herbal Formulae. BMC Bioinform. 2010, 11 Suppl 11, S6. DOI: 10.1186/1471-2105-11-S11-S6.
   PubMed Web of Science ®Google Scholar
• Mokhtari, R. B.; Homayouni, T. S.; Baluch, N.; Morgatskaya, E.; Kumar, S.; Das, B.; Yeger, H. Combination Therapy in Combating Cancer. Oncotarget 2017, 8, 38022–38043. DOI: 10.18632/oncotarget.16723.
   PubMedGoogle Scholar
• Ma, Z.; Li, N.; Zhang, B.; Hui, Y. Y.; Zhang, Y.; Lu, P.; Pi, J.; Liu, Z. Dual Drug-Loaded Nano-Platform for Targeted Cancer Therapy: Toward Clinical Therapeutic Efficacy of Multi-Functionality. J. Nanobiotechnol. 2020, 18, 123. DOI: 10.1186/s12951-020-00681-8.
   PubMed Web of Science ®Google Scholar
• Lv, S.; Tang, Z.; Li, M.; Lin, J.; Song, W.; Liu, H.; Huang, Y.; Zhang, Y.; Chen, X. Co-Delivery of Doxorubicin and Paclitaxel by PEG-Polypeptide Nanovehicle for the Treatment of Non-small Cell Lung Cancer. Biomaterials 2014, 35, 6118–6129. DOI: 10.1016/j.biomaterials.2014.04.034.
   PubMed Web of Science ®Google Scholar
• Zhang, P.; Li, J.; Ghazwani, M.; Zhao, W.; Huang, Y.; Zhang, X.; Venkataramanan, R.; Li, S. Effective Co-delivery of Doxorubicin and Dasatinib Using a PEG-Fmoc Nanocarrier for Combination Cancer Chemotherapy. Biomaterials 2015, 67, 104–114. DOI: 10.1016/j.biomaterials.2015.07.027.
   PubMed Web of Science ®Google Scholar
• Jin, X.; Zou, B.; Luo, L.; Zhong, C.; Zhang, P.; Cheng, H.; Guo, Y.; Gou, M. Co Delivery of Thioridazine and Doxorubicin Using Nanoparticles for Effective Breast Cancer Therapy. Int. J. Nanomed. 2016, 11, 4545–4552. DOI: 10.2147/IJN.S104635.
   PubMed Web of Science ®Google Scholar
• Amin, M. U.; Khurram, M.; Khattak, B.; Khan, J. Antibiotic Additive and Synergistic Action of Rutin, Morin and Quercetin against Methicillin Resistant Staphylococcus aureus. BMC Complement. Altern. Med. 2015, 15, 59. DOI: 10.1186/s12906-015-0580-0.
   PubMed Web of Science ®Google Scholar
• Zhang, M.; Wang, Q.; Zhou, H. Investigation of the Interactions of Quercetin and Morin with Trypsin. Luminescence 2009, 24, 355–362. DOI: 10.1002/bio.1121.
   PubMed Web of Science ®Google Scholar
• Yarjanli, Z.; Ghaedi, K.; Esmaeili, A.; Zarrabi, A.; Rahgozar, S. The Antitoxic Effects of Quercetin and Quercetin-Conjugated Iron Oxide Nanoparticles (QNPs) against H2O2-Induced Toxicity in PC12 Cells. Int. J. Nanomed. 2019, 14, 6813–6830. DOI: 10.2147/IJN.S212582.
   PubMed Web of Science ®Google Scholar
• Kandemir, K.; Tomas, M.; McClements, D. J.; Capanoglu, E. Recent Advances on the Improvement of Quercetin Bioavailability. Trends Food Sci. Technol. 2022, 119, 192–200. DOI: 10.1016/j.tifs.2021.11.032.
   Web of Science ®Google Scholar
• Gaba, B.; Fazil, M.; Ali, A.; Baboota, S.; Sahni, J. K.; Ali, J. Nanostructured Lipid (NLCs) Carriers as a Bioavailability Enhancement Tool for Oral Administration. Drug Deliv. 2015, 22, 691–700. DOI: 10.3109/10717544.2014.898110.
   PubMed Web of Science ®Google Scholar
• Bibhas, C. M.; Gitanjali, M.; Subas, C. D.; Narahari, N. P. Exploring the Use of Lipid Based Nano-Formulations for the Management of Tuberculosis. J. Nanosci. Curr. Res. 2017, 02, 1–15. DOI: 10.4172/2572-0813.1000112.
   Google Scholar
• Poonia, N.; Kharb, R.; Lather, V.; Pandita, D. Nanostructured Lipid Carriers: Versatile Oral Delivery Vehicle. Future Sci. 2016, 2, 1–24. DOI: 10.4155/fsoa-2016-0030.
   Google Scholar
• Sahoo, B. M.; Kumar, B. V. V. R.; Patra, C. N.; Panda, J. R.; Mohanta, B. C.; Palei, N. N. Nanotechnology: A Novel Approach for Drug Development in Health Care System. CNM. 2020, 5, 12–25. DOI: 10.2174/2405461505666200320152824.
   Google Scholar
• Carbone, C.; Leonardi, A.; Cupri, S.; Puglisi, G.; Pignatello, R. Pharmaceutical and Biomedical Applications of Lipid-Based Nanocarriers. Pharm. Pat. Anal. 2014, 3, 199–215. DOI: 10.4155/ppa.13.79.
   PubMedGoogle Scholar
• Palei, N. N.; Mohanta, B. C.; Sabapathi, M. L.; Das, M. K. Lipid-Based Nanoparticles for Cancer Diagnosis and Therapy. In Organic Materials as Smart Nanocarriers for Drug Delivery, Grumezescu A. M., Ed.; Elsevier Science, William Andrew Publishing, 2018; pp. 415–470. DOI: 10.1016/B978-0-12-813663-8.00010-5.
   Google Scholar
• Mohanta, B. C.; Dinda, S. C.; Palei, N. N.; Deb, J. Solid Lipid Based Nano-Particulate Formulations in Drug Targeting. In Role of Novel Drug Delivery Vehicles in Nanobiomedicine IntechOpen, Tyagi R. K., Garg N., Shukla R., Bisen P. S., Eds., 2019; pp. 1–30. DOI: 10.5772/intechopen.88268.
   Google Scholar
• Mohanta, B. C.; Palei, N. N.; Surendran, V.; Dinda, S. C.; Rajangam, J.; Deb, J.; Sahoo, B. M. Lipid Based Nanoparticles: Current Strategies for Brain Tumor Targeting. CNM. 2019, 4, 84–100. DOI: 10.2174/2405461504666190510121911.
   Google Scholar
• Palei, N. N.; Mohanta, B. C.; Das, M. K.; Sabapathi, M. L. Lornoxicam Loaded Nanostructured Lipid Carriers for Topical Delivery: Optimization, Skin Uptake and In vivo Studies. J. Drug Delivery. Sci. Technol. 2017, 39, 490–500. DOI: 10.1016/j.jddst.2017.05.001.
   Web of Science ®Google Scholar
• Palei, N. N.; Das, M. K. Preparation and Characterization of Lornoxicam Loaded Solid Lipid Nanoparticles Made from Different Lipids. Int. J. Pharm. PharmSci. 2013, 5, 438–442.
   Google Scholar
• Mohanta, B. C.; Dinda, S. C.; Palei, N. N.; Mishra, G. Quality by Design Approach for Fabrication of Rifampicin-Loaded Solid Lipid Nanoparticles: Effect on Formulation and Characteristic Parameters. Asian J. Pharm. 2020, 14, 111–122. DOI: 10.22377/ajp.v14i1.3536.
   Web of Science ®Google Scholar
• Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using Microculture Tetrazolium Assay. Cancer Res. 1988, 48, 589–601.
   PubMed Web of Science ®Google Scholar
• Mosmann, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Method. 1983, 65, 55–63. DOI: 10.1016/0022-1759(83)90303-4.
   PubMed Web of Science ®Google Scholar
• Mohanta, B. C.; Dinda, S. C.; Mishra, G.; Palei, N. N.; Azger Dusthackeer, V. N. Formulation, Characterization, In vitro anti-Tubercular Activity and Cytotoxicity Study of Solid Lipid Nanoparticles of Isoniazid. Nano BioMed. Eng. 2018, 10, 379–391. DOI: 10.5101/nbe.v10i4.p379-391.
   Google Scholar
• Fathi, H. A.; Allam, A.; Elsabahy, M.; Fetih, G.; El-Badry, M. Nanostructured Lipid Carriers for Improved Oral Delivery and Prolonged Antihyperlipidemic Effect of Simvastatin. Colloids Surf. B. Biointerf. 2018, 162, 236–245. DOI: 10.1016/j.colsurfb.2017.11.064.
   PubMed Web of Science ®Google Scholar
• Teng, Z.; Yu, M.; Ding, Y.; Zhang, H.; Shen, Y.; Jiang, M.; Liu, P.; Damoah, Y. O.; Webster, T. J.; Zhou, J. Preparation and Characterization of Nimodipine Loaded Nanostructured Lipid Systems for Enhanced Solubility and Bioavailability. Int. J. Nanomed. 2019, 14, 119–133. DOI: 10.2147/IJN.S186899.
   PubMed Web of Science ®Google Scholar
• Sachan, A. K.; Gupta, A.; Arora, M. Formulation and Characterization of Nanostructured Lipid Carriers (NLC) Based Gel for Topical Delivery of Eterocoxib. J. Drug Deliv. Ther. 2016, 6, 4–13. DOI DOI: 10.22270/jddt.v6i2.1222.
   Google Scholar
• El-Say, K. M.; Hosny, K. M. Optimization of Carvedilol Solid Lipid Nanoparticles: An Approach to Control the Release and Enhance the Oral Bioavailability on Rabbits. PLoS One. 2018, 13, e0203405. DOI: 10.1371/journal.pone.0203405.
   PubMed Web of Science ®Google Scholar
• Oliveira, M. S.; Aryasomayajula, B.; Pattni, B.; Mussi, S. V.; Ferreira, L. A. M.; Torchilin, V. P. Solid Lipid Nanoparticles co-Loaded with Doxorubicin and α-Tocopherol Succinate Are Effective against Drug-Resistant Cancer Cells in Monolayer and 3-D Spheroid Cancer Cell Models. Int. J. Pharm. 2016, 512, 292–300. DOI: 10.1016/j.ijpharm.2016.08.049.
   PubMed Web of Science ®Google Scholar
• Sabapati, M. L.; Palei, N. N.; Ashok, K. C. K.; Molakpogu, R. B. Solid Lipid Nanoparticles of Annona Muricata Fruit Extract: Formulation, Optimization and in Vitro Cytotoxicity Studies. Drug Dev. Ind. Pharm. 2019, 45, 577–586. DOI: 10.1080/03639045.2019.1569027.
   PubMed Web of Science ®Google Scholar